
    
      Prospective, single-arm, single center, non-randomized feasibility study of the CorPath GRX
      POP System to examine its performance during remote angioplasty (ballooning) and stenting and
      patient outcomes through 48 hours post-PCI procedure hospital discharge, whichever occurs
      first.
    
  